Type 2 Diabetes Medicines Exporter India to USA | City Drug House
City Drug House is a trusted exporter of Semasize 1 mg/ml injection from India to the USA and Washington. We provide high-quality diabetes medicines with secure packaging, competitive pricing, and timely international delivery for global pharmaceutical buyers.
Semasize 1 mg/ml injection is a weekly, subcutaneous GLP-1 receptor agonist containing semaglutide. It manages Type 2 Diabetes and aids weight loss by mimicking the GLP-1 hormone to increase glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying, leading to improved glycemic control and reduced appetite.
Key Pharmacological Actions:
Mechanism of Action: As a GLP-1 receptor agonist, it binds to and activates the GLP-1 receptor, stimulating insulin release from pancreatic beta cells when blood sugar is high and inhibiting glucagon secretion.
Appetite Regulation: It acts on appetite centers in the brain to increase satiety, reduce hunger, and lower calorie intake, which supports long-term weight management.
Gastric Emptying: It slows gastric emptying, which reduces post-meal blood sugar spikes.
Pharmacokinetics: Administered via subcutaneous injection (often in the abdomen, thigh, or upper arm). It has a long elimination half-life of approximately 7 days, allowing for once-weekly dosing.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA , Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
